B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Dna Recombinant

300 PubMed studies analyzed · 9 RCTs · Evidence Score: 45.9

Research Domains

Dna Recombinant has been studied across 13 research domains including 🛡️ Immunity, 🔬 Oncology, 🧬 Hormones, 🫁 Liver & Detox, 🔥 Metabolic. The primary research focus is 🛡️ Immunity with 19% of studies addressing this area.

Loading evidence profile...

This evidence profile for Dna Recombinant is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.